Skip to main content
. Author manuscript; available in PMC: 2016 Aug 23.
Published in final edited form as: Ophthalmology. 2015 Jan 21;122(5):1016–1022. doi: 10.1016/j.ophtha.2014.11.029

Figure 3.

Figure 3

Representative case with vitreous seeds. Following successful completion of first course OAC, the tumor recurs with vitreous disease (yellow arrows) (A). Recurrent tumor responds to second-course OAC (B) but vitreous disease (yellow arrows) worsens and the eye was enucleated (C).